FQHCs - mPATH | Cancer Screening Navigation Platform
Upcoming Webinar — The Digital Divide Is Closing: What It Means for Patient Engagement & What Most Health Systems Are Getting Wrong. April 22–23 →
For FQHCs

Your screening rates are on the line. Your navigators are maxed out. There's a better way.

mPATH is a cancer screening navigation platform that doubles screening completion — proven in the populations FQHCs serve, funded by state partnerships, and live in days.

Proven in low-income populations
Community Health Centers
+9 pts
At Blue Ridge Health
Published in JAMA
Peer-Reviewed Evidence
Get Pricing
The Challenge

HRSA UDS deadlines don't wait. Manual outreach doesn't scale.

UDS quality scores are at stake

Cancer screening rates directly impact HRSA reporting, funding, and compliance. Every missed patient counts.

Navigator math doesn't work

At $80K–$100K per navigator handling 200–300 patients, you can't reach your full eligible population. Burnout is constant, hiring is slow.

The patients most overdue are the hardest to reach

They don't use portals, don't respond to letters, and miss visits. Mass texts generate opens, not completions.

Why mPATH

Built for the populations FQHCs serve. Proven in peer-reviewed trials.

mPATH was originally developed and tested in community health center settings with low-income, low-literacy populations. The Annals of Internal Medicine trial showed 2.5x screening completion in exactly these populations. This isn't a tool built for academic medical centers and adapted down — it was built here first.

2x
Screening completion (Annals RCT, low-income population)
53%
Patient self-ordering (no provider visit needed)
+9 pts
CRC screening at Blue Ridge Health in 3 months
92%
Rated easy to use (including limited-literacy patients)
Funding & Partnerships

State funding partnerships can offset your costs.

The NC DHHS partnership model shows how state funding can offset deployment costs. Blue Ridge Health deployed mPATH at approximately $60K via state funding. Medicaid MCO pass-through arrangements can also help offset costs. mPATH helps identify available funding pathways for your organization, ensuring that cancer screening improvements don't strain your operational budget.

How It Works

State health departments recognize that FQHCs are the backbone of cancer screening access for underserved populations. mPATH partnerships leverage state funding to support deployment, with costs proportional to your patient population size.

Health Equity

Published proof of effectiveness across every demographic.

CMS equity-linked reimbursement and community benefit reporting require demonstrated improvement across demographics. mPATH has published effectiveness data across race, ethnicity, income, and literacy level — not just aggregate numbers. This means you can confidently report screening improvements to HRSA, CMS, and your board with stratified outcome data that proves equitable impact.

Evidence by Population

Our research spans low-income, uninsured, and underinsured populations across rural and urban settings. Every demographic showed sustained improvement in screening completion, addressing the core FQHC mission of health equity.

How It Works

Upload a patient file. mPATH handles the rest.

01

Upload eligible patient list

CSV from any EHR. mPATH integrates with your data in minutes, not months.

02

mPATH navigates the full journey

Education, motivation, eligibility verification, and self-scheduling via SMS — all built on behavioral science.

03

Staff manage the queue

Patients who said yes flow into a queue. Documentation ready for scheduling and provider handoff.

See what mPATH would do with your patient population.

We'll model the impact against your UDS targets and screening goals.

Media Inquiries

For press and media inquiries, reach us here.

Stay Updated

Get the latest on value-based care, clinical AI, and mPATH updates.

Contact Us